Drug Discovery World

FEBRUARY 5, 2024

Williams discussed the advantages of the company’s ‘disease agnostic’ small molecule degraders, and its success so far in translating results from preclinical to clinical tests in dermatology, inflammation and oncology indications. Life sciences and diagnostics company Revvity showcased over 40 products at SLAS2024, alongside new branding.

Gene Therapy 64

Gene Therapy Life Science Production Dermatology 64

XTalks

AUGUST 7, 2023

Verrica, a company specializing in dermatology therapeutics, has designed Ycanth to be delivered through a single-use applicator. Efficacy and Safety of Ycanth The effectiveness of Ycanth was evaluated in two randomized, double-blind, placebo-controlled Phase III clinical trials, identified as Trial 1 and Trial 2.

FDA Approval 98

FDA Approval Dermatology Trials Clinical Trials 98

XTalks

JUNE 20, 2022

The results of their Phase IIa STP705 clinical study were published in the Journal of Drugs in Dermatology , a peer-reviewed medical journal of dermatology that was established in 2002. Clinical Trial Outcomes of isSCC Treatment with STP705. STP705 — A Promising siRNA Candidate Against isSCC.

RNA 96

RNA Clinical Trials Clinical Trials Dermatology 96

XTalks

MARCH 24, 2023

The company recently presented a pooled analysis from clinical studies of their DermaSensor skin cancer detection device at the American Academy of Dermatology (AAD) 2023 Annual Meeting. DermaSensor is a health-technology company focused on developing non-invasive tools to better equip primary care physicians for skin cancer detection.

Dermatology 97

Dermatology Clinical Trials Clinical Trials Sales 97

XTalks

MAY 26, 2023

The safety and efficacy of Vyjuvek were evaluated in the Phase III randomized, double-blinded, placebo-controlled GEM-3 trial involving 31 patients with DEB, including 30 with the recessive type and one with the dominant type. Results of the trials are published in the journals Nature Medicine and The New England Journal of Medicine.

Gene Therapy 97

Gene Therapy Gene FDA Approval Dermatology 97

XTalks

MAY 22, 2023

It’s an extremely important factor I consider in my therapeutic process of restoring their natural beauty and appearance,” said Macrene Alexiades, MD, PhD, dual US-EU board-certified dermatologist, SkinVive by Juvéderm lead investigator and author of the clinical trial published in Dermatologic Surgery.

Filler 92

Filler FDA Approval Dermatology Production 92

XTalks

SEPTEMBER 22, 2022

Clinical Trial Behind Spevigo. The efficacy of Spevigo (spesolimab) was determined based on the results of the Effisayil 1 double-blind, randomized, Phase II clinical trial. Waldman Department of Dermatology. Spevigo is the first approved treatment option for GPP in adults.

FDA Approval 52

FDA Approval Clinical Trials Clinical Trials Dermatology 52

XTalks

MAY 31, 2022

XTALKS WEBINAR: All Means All: The Road to Inclusivity in Clinical Trials. Register for this free webinar to learn what the FDA’s new draft guidance means for diverse and inclusive trials. The featured speakers will discuss its shortcomings and what the industry still needs to address to make clinical trials more inclusive for all.

FDA Approval 98

FDA Approval Clinical Trials Clinical Trials Trials 98

XTalks

JANUARY 2, 2024

XTALKS WEBINAR: Strategic Design Decisions in Rare Disease Trials Live and On-Demand: Thursday, February 8, 2024, at 11 am EST (4 pm GMT/UK) Register for this free webinar to discover invaluable strategies to effectively navigate rare disease trials, enhancing endpoint adaptation, data quality and clinical interpretation.

FDA Approval 111

FDA Approval Gene Therapy Gene Trials 111

XTalks

JANUARY 12, 2024

Zelsuvmi’s future was also in question after the drug had failed in two of Novan’s Phase III trials. The FDA’s approval of Zelsuvmi was based on data from two Phase III clinical trials, B-SIMPLE 4 and B-SIMPLE 2, involving 1,598 patients. However, less than six months later, Ligand’s gamble paid off with an approval.

FDA Approval 64

FDA Approval Trials Clinical Trials Clinical Trials 64

XTalks

DECEMBER 15, 2020

Synteract has a solid reputation in the emerging biopharma sphere, providing therapeutic expertise in areas including oncology, rare and orphan diseases, neuroscience, dermatology and pediatrics. Synteract’s client base largely consists of pre-revenue companies, a segment in which Syneos Health sees growth opportunities for itself.

Dermatology 98

Dermatology Clinical Trials Clinical Trials Branding 98

XTalks

SEPTEMBER 14, 2022

Daxxify is effective, as safe as competitors, and has been well tolerated in clinical trials. The approval of Daxxify was based on data generated in a series of clinical trials, the SAKURA Phase III clinical trial program ( 1 , 2 and 3 ). A Novel Botox Competitor. Bringing Daxxify into Offices.

Botox 98

Botox FDA Approval Cosmetics Clinical Trials 98

Drug Discovery World

APRIL 15, 2024

Reece Armstrong speaks to Sean McClain , Founder & CEO of Absci about the rise of generative AI in life sciences. We’ve never had that ability to specifically design molecules the way we’ve wanted to, we’ve always had to rely on this trial-and-error process. And so I think this is a big step forward.

Antibody 59

Antibody Drugs In-Vivo Life Science 59

XTalks

DECEMBER 14, 2023

However, its uses expanded over the years into other indications, ranging from parasitic infection to dermatology. The Consortium represents a group of over 50 hospitals that offer collaboration through a network of childhood cancer clinical trials.” Although a rare cancer, it is one of the more common childhood cancers.

FDA Approval 52

FDA Approval Dermatology Drugs DNA 52

XTalks

DECEMBER 15, 2020

Synteract has a solid reputation in the emerging biopharma sphere, providing therapeutic expertise in areas including oncology, rare and orphan diseases, neuroscience, dermatology and pediatrics. Synteract’s client base largely consists of pre-revenue companies, a segment in which Syneos Health sees growth opportunities for itself.

Dermatology 52

Dermatology Clinical Trials Clinical Trials Branding 52

XTalks

JUNE 14, 2021

Related: Google Launches AI-Based Dermatology Assist Tool. Some might see this as an effort on Amazon’s part to combat the harsh criticism it has received since the beginning of the pandemic for failing to provide safe workplace conditions and unpaid sick leave to its employees. 263, and meet the requirements to perform high-complexity tests.

Biohazard 59

Biohazard Biohazard Dermatology Clinical Trials 59

XTalks

MARCH 10, 2022

The unsealed asbestos experiment files were unearthed in two trials last year pertaining to the baby powder. Last year, Penn’s medical school apologized for Kligman’s testing and renamed his dermatology professorship after a Black colleague.

Containment 98

Containment Dermatology Contamination Sales 98

XTalks

AUGUST 2, 2023

This is largely due to failed trials as a prophylaxis resulting in the European Committee for Medical Products (CHMP) recommending against the approval of Lagevrio. There was a record 34 approvals in major markets, and late-stage trials are commencing for medications including camizestrant, datopotamab deruxtecan and volrustomig.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

JANUARY 26, 2021

Reddy’s”) and Global Response Aid FZCO (GRA) today announced the termination of Avigan Trial Study conducted in Kuwait focused on moderate to severe COVID patients in a hospital setting. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.

Life Science 40

Life Science Production Marketing Dermatology 40